shear-activated nanotherapeutics drug targeting obstructed blood vessels
obstruction critical blood vessels due thrombosis embolism leading cause death worldwide describe biomimetic strategy uses high shear stress caused vascular narrowing targeting mechanism-in way platelets do-to deliver drugs obstructed blood vessels microscale aggregates nanoparticles fabricated break nanoscale components exposed abnormally high fluid shear stress coated tissue plasminogen activator administered intravenously mice shear-activated nanotherapeutics induce rapid clot dissolution mesenteric injury model restore normal flow dynamics increase survival otherwise fatal mouse pulmonary embolism model biophysical strategy drug targeting lowers required doses minimizes side effects maximizing drug efficacy offers potential new approach treatment life-threatening diseases result acute vascular occlusion
